tiprankstipranks
Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
US Market

Panbela Therapeutics (PBLA) Technical Analysis

Compare
245 Followers

Technical Sentiment

Overall Consensus
Strong Sell
1Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Panbela Therapeutics’s (PBLA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Panbela Therapeutics is a Sell.
Panbela Therapeutics’s (PBLA) 20-Day exponential moving average is 0.37, while Panbela Therapeutics’s (PBLA) share price is $0.34, making it a Sell.
Panbela Therapeutics’s (PBLA) 50-Day exponential moving average is 0.36, while Panbela Therapeutics’s (PBLA) share price is $0.34, making it a Sell.

Panbela Therapeutics (PBLA) Pivot Points

Mar 04, 2025, 03:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.22
0.28
0.33
0.39
0.43
0.49
0.54
Fibonacci
0.28
0.32
0.35
0.39
0.43
0.45
0.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Panbela Therapeutics (PBLA) Moving Averages

Mar 04, 2025, 03:51 PM
Period
Simple
Exponential
MA5
0.39Sell
0.38Sell
MA10
0.38Sell
0.38Sell
MA20
0.36Sell
0.37Sell
MA50
0.37Sell
0.36Sell
MA100
0.35Sell
0.36Sell
MA200
0.36Sell
0.39Sell
Panbela Therapeutics’s (PBLA) 10-Day exponential moving average is 0.38, while Panbela Therapeutics’s (PBLA) share price is $0.34, making it a Sell.
Panbela Therapeutics’s (PBLA) 100-Day exponential moving average is 0.36, while Panbela Therapeutics’s (PBLA) share price is $0.34, making it a Sell.
Panbela Therapeutics’s (PBLA) stock price is $0.34 and Panbela Therapeutics’s (PBLA) 50-day simple moving average is 0.37, creating a Sell signal.
Panbela Therapeutics’s (PBLA) stock price is $0.34 and Panbela Therapeutics’s (PBLA) 100-day simple moving average is 0.35, creating a Sell signal.
Panbela Therapeutics’s (PBLA) stock price is $0.34 and Panbela Therapeutics’s (PBLA) 200-day simple moving average is 0.36, creating a Sell signal.

Panbela Therapeutics (PBLA) Technical Indicators

Mar 04, 2025, 03:51 PM
Name
Value
Implied Action
RSI (14)
44.30
Neutral
STOCH (9,6)
37.69
Neutral
STOCHRSI (14)
42.76
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
33.35
Neutral
Williams %R
-79.52
Buy
CCI (14)
-20.13
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
41.07
Neutral
ROC
0.00
Buy
Panbela Therapeutics’s (PBLA) Relative Strength Index (RSI) is 44.30, creating a Neutral signal.
Panbela Therapeutics’s (PBLA) Trend Strength Indicator (ADX) is 33.35, creating a Neutral signal.
Panbela Therapeutics’s (PBLA) Commodity Channel Index (CCI) is -20.13, creating a Neutral signal.

FAQ

Is PBLA a Buy, Hold, or Sell?
Based on PBLA’s technical indicators, PBLA is a Strong Sell.
    What is PBLA’s RSI (14)?
    PBLA’s RSI (14) is 44.30, which suggests PBLA is a Neutral.
      What is PBLA’s MACD?
      PBLA’s MACD is <0.01, which suggests PBLA is a Sell.
        What is PBLA’s 5-day moving average?
        PBLA’s 5-day moving average is 0.39, which suggests PBLA is a Sell.
          What is PBLA’s 20-day moving average?
          PBLA 20-day moving average is 0.36, which suggests PBLA is a Sell.
            What is PBLA’s 50-day moving average?
            PBLA’s 50-day moving average is 0.37, which suggests PBLA is a Sell.
              What is PBLA’s 200-day moving average?
              PBLA’s 200-day moving average is 0.36, which suggests PBLA is a Sell.
                What is PBLA’s Williams % R (14)?
                PBLA’s Williams % R (14) is -79.52, which suggests PBLA is a Buy.
                  What is PBLA’s CCI (14)?
                  PBLA’s CCI (14) is -20.13, which suggests PBLA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis